Smith R J, Sly L M
Department of Cell Biology and Inflammation Research, Pharmacia & Upjohn, Inc., Kalamazoo, Michigan, USA.
J Pharmacol Exp Ther. 1996 Jun;277(3):1801-13.
Diabetic-resistant (DR) BioBreeding (BB) rats developed an erosive hind paw arthritis when immunized with an emulsion of bovine type II collagen (CII) and incomplete Freund's adjuvant. Macroscopic clinical evidence of type II collagen-induced arthritis (CIA) first appeared as periarticular erythema and edema in the hind paws between days 9 and 10 postimmunization with CII. The incidence of CIA was 100% by day 11 in the CII-challenged rats; and CIA severity progressed over a 28-day period with radiographic evaluation revealing focal resorption of bone together with osteophyte formation in the tibiotarsal joint and soft tissue swelling. The histopathology of CIA included an hyperplastic synovium that invaded and eroded articular cartilage at the joint margins, and subchondral bone resorption associated with bone-derived, multinucleated cell-containing granulomatous lesions in the rat hind paw. The corticosteroid, methylprednisolone (medrol), and the nonsteroidal antiinflammatory drug, flurbiprofen (Ansaid), administered at 2 mg/kg (p.o.), suppressed the clinical signs of CIA, and caused 79 to 83% inhibition of hind paw inflammation. However, methylprednisolone, but not flurbiprofen, inhibited the joint pathology in CIA. The antirheumatic drugs, cyclophosphamide (cytoxan, 5 mg/kg, p.o.) and cyclosporin A (CsA, 25 mg/kg, p.o.) suppressed the cartilage erosion in inflamed rat joints, and exerted marked inhibition (89-100%) of hind paw swelling. Methotrexate (0.15 mg/kg, p.o.) treatment reduced hind paw swelling (48%), whereas azathioprine, D-penicillamine (DP) and the oral gold preparation, auranofin, were inactive. Anti-CII antibody titers were completely suppressed by cyclosporin A and cytoxan. Radiographic evidence of protection from bone resorption, osteophyte formation and soft tissue swelling was apparent in the tibiotarsal joints of cytoxan, cyclosporin A, methylprednisolone and methotrexate-treated rat.
糖尿病抵抗(DR)生物繁殖(BB)大鼠在用牛II型胶原(CII)与不完全弗氏佐剂的乳剂免疫后会发生侵蚀性后爪关节炎。II型胶原诱导的关节炎(CIA)的宏观临床证据首先表现为在CII免疫后第9至10天之间后爪的关节周围红斑和水肿。在接受CII攻击的大鼠中,到第11天时CIA的发生率为100%;CIA的严重程度在28天内进展,放射学评估显示骨的局灶性吸收以及跗关节处骨赘形成和软组织肿胀。CIA的组织病理学包括增生的滑膜,其侵入并侵蚀关节边缘的关节软骨,以及与大鼠后爪中骨源性、含多核细胞的肉芽肿性病变相关的软骨下骨吸收。以2mg/kg(口服)给药的皮质类固醇甲泼尼龙(美卓乐)和非甾体抗炎药氟比洛芬(安赛蜜)抑制了CIA的临床症状,并导致后爪炎症抑制79%至83%。然而,甲泼尼龙而非氟比洛芬抑制了CIA中的关节病理变化。抗风湿药物环磷酰胺(癌得星,5mg/kg,口服)和环孢素A(CsA,25mg/kg,口服)抑制了炎症大鼠关节中的软骨侵蚀,并对后爪肿胀产生了显著抑制(89% - 100%)。甲氨蝶呤(0.15mg/kg,口服)治疗减少了后爪肿胀(48%),而硫唑嘌呤、D - 青霉胺(DP)和口服金制剂金诺芬则无活性。环孢素A和环磷酰胺完全抑制了抗CII抗体滴度。在环磷酰胺、环孢素A、甲泼尼龙和甲氨蝶呤治疗的大鼠的跗关节中,有明显的影像学证据表明可防止骨吸收、骨赘形成和软组织肿胀。